Black Rock Inc. Bio Cardia, Inc. Transaction History

Black Rock Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.38 - $0.68 $1,187 - $2,124	3,124 Added 7.3%	45,891 $18,000
Q4 2023 Feb 13, 2024	BUY	$0.37 - $1.07 $4,088 - $11,822	11,049 Added 34.84%	42,767 $28,000
Q3 2023 Nov 13, 2023	SELL	$0.37 - $2.85 $479 - $3,690	-1,295 Reduced 3.92%	31,718 $13,000
Q2 2023 Aug 11, 2023	BUY	$1.52 - $2.8 $50,179 - $92,436	33,013 New	33,013 $88,000
Q2 2022 Aug 12, 2022	SELL	$17.7 - $32.55 $609,428 - $1.12 Million	-34,431 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$21.3 - $39.0 $35,847 - $65,637	-1,683 Reduced 4.66%	34,431 $72,000
Q4 2021 Feb 10, 2022	BUY	$25.65 - $46.05 $23,982 - $43,056	935 Added 2.66%	36,114 $70,000
Q3 2021 Nov 09, 2021	SELL	$42.6 - $58.65 $31,864 - $43,870	-748 Reduced 2.08%	35,179 $110,000
Q2 2021 Aug 11, 2021	BUY	$48.9 - $74.85 $1.76 Million - $2.69 Million	35,927 New	35,927 $143,000

Ticker BCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,758,200
Market Cap $39.8M
Description
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.